Voices
Amy C. Moore: Important Case Study Using Methylation-Based ctDNA Assays in EGFR+ NSCLC
Amy C. Moore and Tejas Patil

Amy C. Moore: Important Case Study Using Methylation-Based ctDNA Assays in EGFR+ NSCLC

Amy C. Moore, Director of Patient Engagement and Advocacy at Summit Therapeutics, Inc., shared a post on LinkedIn:

“Important and fascinating lung cancer case study by Dr. Tejas Patil and team using methylation based ctDNA assays to follow SCLC evolution in patient with EGFR+ NSCLC.”

Title: Longitudinal, Retrospective Use of a Circulating Tumor DNA Methylation Signature Successfully Captures Small Cell Evolution in a Patient With Metastatic EGFR-Mutant Non–Small Cell Lung Cancer

Authors: Tejas Patil, Amy Guimarães-Young, Jill Tsai, Dara L. Aisner, Leslie Bucheit, Anton Valouev

Read the Full Article.

Amy C. Moore: Important Case Study Using Methylation-Based ctDNA Assays in EGFR+ NSCLC

Other articles about NSCLC on OncoDaily.

Amy C. Moore cancer lung cancer c OncoDaily Oncology SCLC Tejas Patil